BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2503655)

  • 21. He is happy whom the Muses love. Micronase (sulfonylurea) overdose.
    Mack RB
    N C Med J; 1989 Jun; 50(6):312-4. PubMed ID: 2500605
    [No Abstract]   [Full Text] [Related]  

  • 22. The sulfonylurea controversy: much ado about nothing or cause for concern?
    Brady PA; Jovanovic A
    J Am Coll Cardiol; 2003 Sep; 42(6):1022-5. PubMed ID: 13678924
    [No Abstract]   [Full Text] [Related]  

  • 23. Do ATP-sensitive potassium channels play a role in myocardial stunning?
    Gross GJ
    Basic Res Cardiol; 1995; 90(4):266-8. PubMed ID: 8534242
    [No Abstract]   [Full Text] [Related]  

  • 24. Potassium channels: basic aspects, functional roles, and medical significance.
    Yost CS
    Anesthesiology; 1999 Apr; 90(4):1186-203. PubMed ID: 10201693
    [No Abstract]   [Full Text] [Related]  

  • 25. [Inappropriate use of sulfonylureas in older adults].
    Pacheco J
    Rev Med Chil; 2016 Nov; 144(11):1497. PubMed ID: 28394970
    [No Abstract]   [Full Text] [Related]  

  • 26. [Reply. Inappropriate use of sulfonylureas in older adults].
    Passi Á
    Rev Med Chil; 2016 Nov; 144(11):1497-1498. PubMed ID: 28394971
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of neuroprotective EETs and sulfonylurea metabolism in relation with K
    Yasar U; Babaoglu MO
    Acta Pharmacol Sin; 2019 Apr; 40(4):569-570. PubMed ID: 30254364
    [No Abstract]   [Full Text] [Related]  

  • 28. Interactive regulation of the ATP-sensitive potassium channel of cardiac muscle.
    Findlay I
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S6-11. PubMed ID: 7898107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATP-sensitive potassium channels, transmural ischemia and the ECG implications for the non-insulin dependent diabetic patient?
    Wilde AA
    Cardiovasc Res; 1996 May; 31(5):688-90. PubMed ID: 8763397
    [No Abstract]   [Full Text] [Related]  

  • 30. [ATP-sensitive potassium channels and substances affecting them].
    Pospísilová Y
    Vnitr Lek; 1998 Jul; 44(7):435-8. PubMed ID: 9748883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulphonylureas, magnesium and cardiac K+ ATP channels.
    Matz R
    Diabetologia; 2000 Aug; 43(8):1080-1. PubMed ID: 10990091
    [No Abstract]   [Full Text] [Related]  

  • 32. ATP-sensitive K+ channels and insulin secretion: their role in health and disease.
    Ashcroft FM; Gribble FM
    Diabetologia; 1999 Aug; 42(8):903-19. PubMed ID: 10491749
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacodynamics of second-generation sulfonylureas: dose-effect curve of gliquidone in type II diabetics].
    Procacci V; Giovine A; Roberto MG; Ronchi AM; Lasorsa G; Vendemiale G; Stufano N; Altomare E
    Boll Soc Ital Biol Sper; 1988 Aug; 64(8):731-8. PubMed ID: 3214573
    [No Abstract]   [Full Text] [Related]  

  • 34. [Identification, function mechanisms and regulation of potassium channels sensitive to ATP which are targets of sulfonylureas used in the treatment of type II diabetes mellitus].
    Fosset M; De Weille J; Schmid-Antomarchi H; Bernardi H; Lazdunski M
    Journ Annu Diabetol Hotel Dieu; 1989; ():7-11. PubMed ID: 2503655
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.